Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
Главные авторы: | Glynne-Jones, R, Sebag-Montefiore, D, Samuel, L, Falk, S, Maughan, T, McDonald, A |
---|---|
Формат: | Conference item |
Опубликовано: |
2005
|
Схожие документы
-
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
по: Glynne-Jones, R, и др.
Опубликовано: (2004) -
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
по: Sebag-Montefiore, D, и др.
Опубликовано: (2005) -
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
по: Glynne-Jones, R, и др.
Опубликовано: (2007) -
Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: A phase II study
по: Evans, T, и др.
Опубликовано: (2006) -
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
по: Anchuan Li, и др.
Опубликовано: (2022-07-01)